These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4988437)

  • 1. [The BCG antibiogram. Diagnostic value of resistance to cycloserine].
    Rist N; Canetti G; Boisvert H; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1967 Nov; 31(7):1060-5. PubMed ID: 4988437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacterial resistance and its relation to chemotherapy].
    Canetti G
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):231-8. PubMed ID: 4973008
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance pattern of Mycobacterium tuberculosis and Mycobacterium bovis to ethambutol.
    Tsukamura M
    Acta Tuberc Pneumol Scand; 1965; 46(2):88-92. PubMed ID: 4964850
    [No Abstract]   [Full Text] [Related]  

  • 4. [Production and laboratory examination of INH-resistant BCG vaccine].
    Milinković M
    Plucne Bolesti Tuberk; 1971; 23(4):347-53. PubMed ID: 4948961
    [No Abstract]   [Full Text] [Related]  

  • 5. Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG.
    Ramón-García S; Martín C; De Rossi E; Aínsa JA
    J Antimicrob Chemother; 2007 Mar; 59(3):544-7. PubMed ID: 17242035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on media for testing resitance to cycloserine. 4. Various lots of cycloserine and the minimal inhibitory concentration to Mycobacterium tuberculosis].
    Tamura M; Takano S
    Iryo; 1967 May; 21(5):550-2. PubMed ID: 4965697
    [No Abstract]   [Full Text] [Related]  

  • 7. [Research for resistance media to Cycloserine. II. The influences of the preservative method of media and the preservative period on the minimal inhibitory concentration of Cycloserine to Mycobacterium tuberculosis].
    Tamura M; Takano S
    Iryo; 1966 Jun; 20(6):573-8. PubMed ID: 4960848
    [No Abstract]   [Full Text] [Related]  

  • 8. [On some aspects of antimycobacterial activity in vitro of cycloserine and terizidone].
    Lucchesi M; Mancini P; Matzeu M
    Ann Ist Carlo Forlanini; 1968; 28(2):105-15. PubMed ID: 4981145
    [No Abstract]   [Full Text] [Related]  

  • 9. [Suitable pH region for resistance test of cycloserine and for the growth of Mycobacterium tuberculosis].
    Tamura M; Takano S
    Kekkaku; 1966 Nov; 41(11):517-23. PubMed ID: 4962768
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
    Ritz N; Tebruegge M; Connell TG; Sievers A; Robins-Browne R; Curtis N
    Antimicrob Agents Chemother; 2009 Jan; 53(1):316-8. PubMed ID: 18955515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubercle bacilli resistance to cycloserine.
    Zierski M; Rózewska M; Woźniak S
    Scand J Respir Dis Suppl; 1970; 71():291-5. PubMed ID: 4989519
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the ofloxacin resistance of tubercle bacilli].
    Tsukamura M; Mizuno S
    Kekkaku; 1985 Oct; 60(10):517-21. PubMed ID: 3935845
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug resistance in the Swedish/Norwegian BCG strain.
    Hesselberg I
    Bull World Health Organ; 1972; 46(4):503-7. PubMed ID: 4559464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
    Taneja NK; Tyagi JS
    J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the effect of cycloserine and kanamycin on Mycobacterium tuberculosis (bacteriological and electron microscopic study)].
    Chertkova EI
    Probl Tuberk; 1965; 43(9):57-62. PubMed ID: 4958492
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of pH of media on the minimal inhibitory concentration of cycloserine to Mycobacterium tuberculosis].
    Tamura M; Takano S
    Kekkaku; 1965 Jun; 40(6):213-8. PubMed ID: 4955433
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety.
    Chen JM; Islam ST; Ren H; Liu J
    Vaccine; 2007 Nov; 25(48):8114-22. PubMed ID: 17954004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microbacterial resistance to antibiotic preparations].
    Savchenko PIu
    Mikrobiol Zh; 1970; 32(3):376-82. PubMed ID: 4996138
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to cycloserine.
    Kreis B
    Scand J Respir Dis Suppl; 1970; 71():266-78. PubMed ID: 4989517
    [No Abstract]   [Full Text] [Related]  

  • 20. Utility of PCR assays for rapid diagnosis of BCG infection in children.
    Su WJ; Huang CY; Huang CY; Perng RP
    Int J Tuberc Lung Dis; 2001 Apr; 5(4):380-4. PubMed ID: 11334259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.